Valproate
- All
- News
-
450 Cases Of Birth Defects From Anti-Epilepsy Drug In France: Health Officials
A common drug used to treat epilepsy has caused congenital defects in around 450 babies in France who were exposed to the medication before birth in the uterus, according to an estimate by health authorities published on Tuesday.
-
Sodium valproate leads to birth defects
Epileptic women who take the anti-seizure drug sodium valproate during pregnancy tend to have a fetus with a serious adverse outcome.
-
Epilepsy drug linked to risk of liver disease
Recent research shows that treatment with the anti-epilepsy drug sodium valproate tends to increase body weight and increase the risk of developing non-alcoholic fatty liver disease (NAFLD).
-
450 Cases Of Birth Defects From Anti-Epilepsy Drug In France: Health Officials
A common drug used to treat epilepsy has caused congenital defects in around 450 babies in France who were exposed to the medication before birth in the uterus, according to an estimate by health authorities published on Tuesday.
-
Sodium valproate leads to birth defects
Epileptic women who take the anti-seizure drug sodium valproate during pregnancy tend to have a fetus with a serious adverse outcome.
-
Epilepsy drug linked to risk of liver disease
Recent research shows that treatment with the anti-epilepsy drug sodium valproate tends to increase body weight and increase the risk of developing non-alcoholic fatty liver disease (NAFLD).
